| ANOVA | Analysis of variance |
| CCC | Lin’s concordance correlation coefficient |
| CHO | Chinese hamster ovary |
| CI | Confidence interval |
| CV | Coefficient of variation |
| DDA | Data-dependent acquisition |
| ddaPASEF | Data-dependent acquisition with parallel accumulation–serial fragmentation |
| DIA | Data-independent acquisition |
| ELISA | Enzyme-linked immunosorbent assay |
| FDP | False discovery proportion |
| FDR | False discovery rate |
| GMP | Good manufacturing practice |
| HC3 | Heteroscedasticity-consistent standard errors (type 3) |
| HCP | Host cell protein |
| Hi3 | Top-three peptide intensity summation |
| ICH | International Council for Harmonisation |
| I–MR | Individuals–Moving Range |
| KDE | Kernel density estimation |
| LC–MS/MS | Liquid chromatography–tandem mass spectrometry |
| LLOQ | Lower limit of quantification |
| LoA | Limits of agreement |
| mAb | Monoclonal antibody |
| MW | Molecular weight |
| ppm | Parts per million (ng HCP per mg product protein) |
| PSM | Peptide-spectrum match |
| REML | Restricted maximum likelihood |
| RTC | Retention time calibration |
| SD | Standard deviation |
| SFSTP | Société Française des Sciences et Techniques Pharmaceutiques |
| SIL-HCP | Stable isotope-labeled host cell protein (standard) |
| SST | System suitability test |
| TE | Total error |
| TI | Tolerance interval |
| TIMS-PASEF | Trapped ion mobility spectrometry with parallel accumulation–serial fragmentation |
| ULOQ | Upper limit of quantification |
| USP | United States Pharmacopeia |
| WLS | Weighted least squares |